|
1
|
Thompson AAR and Lawrie A: Targeting
vascular remodeling to treat pulmonary arterial hypertension.
Trends Mol Med. 23:31–45. 2017. View Article : Google Scholar
|
|
2
|
Task Force for Diagnosis and Treatment of
Pulmonary Hypertension of European Society of Cardiology (ESC);
European Respiratory Society (ERS); International Society of Heart
and Lung Transplantation (ISHLT); Galiè N, Hoeper MM, Humbert M,
Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S,
Gibbs JS, et al: Guidelines for the diagnosis and treatment of
pulmonary hypertension. Eur Heart J. 32:2493–2537. 2009.
|
|
3
|
Naeije R and Dedobbeleer C: Pulmonary
hypertension and the right ventricle in hypoxia. Exp Physiol.
98:1247–1256. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ghofrani HA, Voswinckel R, Reichenberger
F, Weissmann N, Schermuly RT, Seeger W and Grimminger F: Hypoxia-
and non-hypoxia-related pulmonary hypertension-established and new
therapies. Cardiovasc Res. 72:30–40. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kylhammar D and Rådegran G: The principal
pathways involved in the in vivo modulation of hypoxic pulmonary
vasoconstriction, pulmonary arterial remodelling and pulmonary
hypertension. Acta Physiol. 219:728–756. 2017. View Article : Google Scholar
|
|
6
|
McLaughlin VV: Looking to the future: A
new decade of pulmonary arterial hypertension therapy. Eur Respir
Rev. 20:262–269. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu L, Wang J, Khanabdali R, Kalionis B,
Tai X and Xia S: Circular RNAs: Isolation, characterization and
their potential role in diseases. RNA Biol. 14:1715–1721. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Salzman J, Gawad C, Wang PL, Lacayo N and
Brown PO: Circular RNAs are the predominant transcript isoform from
hundreds of human genes in diverse cell types. PLoS One.
7:e307332012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu J, Liu T, Wang X and He A: Circles
reshaping the RNA world: From waste to treasure. Mol Cancer.
16:582017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Han B, Chao J and Yao H: Circular RNA and
its mechanisms in disease: From the bench to the clinic. Pharmacol
Ther. 187:31–44. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Legnini I, Di Timoteo G, Rossi F, Morlando
M, Briganti F, Sthandier O, Fatica A, Santini T, Andronache A, Wade
M, et al: Circ-ZNF609 is a circular RNA that can be translated and
functions in myogenesis. Mol Cell. 66:22–37. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kristensen LS, Hansen TB, Veno MT and
Kjems J: Circular RNAs in cancer: Opportunities and challenges in
the field. Oncogene. 37:555–565. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fan X, Weng X, Zhao Y, Chen W, Gan T and
Xu D: Circular RNAs in cardiovascular disease: An overview. Biomed
Res Int. 2017:51357812017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Floris G, Zhang L, Follesa P and Sun T:
Regulatory role of circular RNAs and neurological disorders. Mol
Neurobiol. 54:5156–5165. 2017. View Article : Google Scholar
|
|
16
|
Shan K, Liu C, Liu BH, Chen X, Dong R, Liu
X, Zhang YY, Liu B, Zhang SJ, Wang JJ, et al: Circular noncoding
RNA HIPK3 mediates retinal vascular dysfunction in diabetes
mellitus. Circulation. 136:1629–1642. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ciuclan L, Bonneau O, Hussey M, Duggan N,
Holmes AM, Good R, Stringer R, Jones P, Morrell NW, Jarai G, et al:
A novel murine model of severe pulmonary arterial hypertension. Am
J Respir Crit Care Med. 184:1171–1182. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods.
25:402–408. 2001. View Article : Google Scholar
|
|
19
|
Wang Y, Mo Y, Gong Z, Yang X, Yang M,
Zhang S, Xiong F, Xiang B, Zhou M, Liao Q, et al: Circular RNAs in
human cancer. Mol Cancer. 16:252017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Enright AJ, John B, Gaul U, Tuschl T,
Sander C and Marks DS: MicroRNA targets iDrosophila. Genome Biol.
5:R12003. View Article : Google Scholar
|
|
21
|
Pasquinelli AE: MicroRNAs and their
targets: Recognition, regulation and an emerging reciprocal
relationship. Nat Rev Genet. 13:271–282. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dweep H and Gretz N: miRWalk2.0: A
comprehensive atlas of microRNA-target interactions. Nat Methods.
12:6972015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vlachos IS, Zagganas K, Paraskevopoulou
MD, Georgakilas G, Karagkouni D, Vergoulis T, Dalamagas T and
Hatzigeorgiou AG: DIANA-miRPath v3.0: Deciphering microRNA function
with experimental support. Nucleic Acids Res. 43:W460–W466. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang W, Liu J, Ma A, Miao R, Jin Y, Zhang
H, Xu K, Wang C and Wang J: mTORC1 is involved in hypoxia-induced
pulmonary hypertension through the activation of Notch3. J Cell
Physiol. 229:2117–2125. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kan M, Shumyatcher M and Himes BE: Using
omics approaches to understand pulmonary diseases. Respir Res.
18:1492017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bienertova-Vasku J, Novak J and Vasku A:
MicroRNAs in pulmonary arterial hypertension: Pathogenesis,
diagnosis and treatment. J Am Soc Hypertens. 9:221–234. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Deng L, Bradshaw AC and Baker AH: Role of
noncoding RNA in vascular remodelling. Curr Opin Lipidol.
27:439–448. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yao JT, Zhao SH, Liu QP, Lv MQ, Zhou DX,
Liao ZJ and Nan KJ: Overexpression of CircRNA_100876 in non-small
cell lung cancer and its prognostic value. Pathol Res Pract.
213:453–456. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu X, Wang X, Wei S, Chen Y, Chen Y, Fan
X, Han S and Wu G: hsa_circ_0013958: A circular RNA and potential
novel biomarker for lung adenocarcinoma. FEBS J. 284:2170–2182.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhuang ZG, Zhang JA, Luo HL, Liu GB, Lu
YB, Ge NH, Zheng BY, Li RX, Chen C, Wang X, et al: The circular RNA
of peripheral blood mononuclear cells: Hsa_circ_0005836 as a new
diagnostic biomarker and therapeutic target of active pulmonary
tuberculosis. Mol Immunol. 90:264–272. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wan QQ, Wu D and Ye QF: The expression
profiles of circRNAs in lung tissues from rats with
lipopolysaccharide-induced acute respiratory distress syndrome: A
microarray study. Biochem Biophys Res Commun. 493:684–689. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Miao R, Wang Y, Wan J, Leng D, Gong J, Li
J, Liang Y, Zhai Z and Yang Y: Microarray expression profile of
circular RNAs in chronic thromboembolic pulmonary hypertension.
Medicine. 96:e73542017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu Y, Huang A, Li T, Su X, Ding H, Li H,
Qin X, Hou L, Zhao Q, Ge X, et al: MiR-152 reduces human umbilical
vein endothelial cell proliferation and migration by targeting
ADAM17. Febs Lett. 588:2063–2069. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu X, Li J, Qin F and Dai S: miR-152 as a
tumor suppressor microRNA: Target recognition and regulation in
cancer. Oncol Lett. 11:3911–3916. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nie L, Zhao YB, Pan JL, Lei Y, Liu M, Long
Y, Zhang JH, Hu Y, Xu MQ, Yuan DZ and Yue LM: Progesterone-induced
miR-152 inhibits the proliferation of endometrial epithelial cells
by down-regulating WNT-1. Reprod Sci. 24:1444–1453. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ge S, Wang D, Kong Q, Gao W and Sun J:
Function of miR-152 as a tumor suppressor in human breast cancer by
targeting PIK3CA. Oncol Res. 25:1363–1371. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sun J, Tian X, Zhang J, Huang Y, Lin X,
Chen L and Zhang S: Regulation of human glioma cell apoptosis and
invasion by miR-152-3p through targeting DNMT1 and regulating NF2:
MiR-152-3p regulate glioma cell apoptosis and invasion. J Exp Clin
Cancer Res. 36:1002017. View Article : Google Scholar :
|
|
38
|
Wang S, Wang L, Dou L, Guo J, Fang W, Li
M, Meng X, Man Y, Shen T, Huang X and Li J: MicroRNA 152 regulates
hepatic glycogenesis by targeting PTEN. FEBS J. 283:1935–1946.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gu S, Ran S, Liu B and Liang J: miR-152
induces human dental pulp stem cell senescence by inhibiting SIRT7
expression. FEBS Lett. 590:1123–1131. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tao J, Liu W, Shang G, Zheng Y, Huang J,
Lin R and Chen L: MiR-207/352 regulate lysosomal-associated
membrane proteins and enzymes following ischemic stroke.
Neuroscience. 305:1–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lu X, Lv S, Mi Y, Wang L and Wang G:
Neuroprotective effect of miR-665 against sevoflurane
anesthesia-induced cognitive dysfunction in rats through PI3K/Akt
signaling pathway by targeting insulin-like growth factor 2. Am J
Transl Res. 9:1344–1356. 2017.PubMed/NCBI
|
|
42
|
Sehgal PB and Mukhopadhyay S: Pulmonary
arterial hypertension: A disease of tethers, SNAREs and SNAPs. Am J
Physiol Heart Circ Physiol. 293:H77–H85. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Fulton D, Li X, Bordan Z, Haigh S, Bentley
A, Chen F and Barman SA: Reactive oxygen and nitrogen species in
the development of pulmonary hypertension. Antioxidants. 6:E542017.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Thenappan T and Weir EK: The nitric oxide
pathway-A potential target for precision medicine in pulmonary
arterial hypertension. Am J Cardiol. 120:S69–S70. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang C, Ma C, Yao H, Zhang L, Yu X, Liu
Y, Shen T, Zhang L, Zhang F, Chen X and Zhu D: 12-Lipoxygenase and
12-hydroxyeicosatetraenoic acid regulate hypoxic angiogenesis and
survival of pulmonary artery endothelial cells via PI3K/Akt
pathway. Am J Physiol Lung Cell Mol Physiol. 314:L606–L616. 2018.
View Article : Google Scholar
|
|
46
|
Xia XD, Lee J, Khan S, Ye L, Li Y and Dong
L: Suppression of phosphatidylinositol 3-kinase/Akt signaling
attenuates hypoxia-induced pulmonary hypertension through the
downregulation of lysyl oxidase. DNA Cell Biol. 35:599–606. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lim CS, Kiriakidis S, Sandison A, Paleolog
EM and Davies AH: Hypoxia-inducible factor pathway and diseases of
the vascular wall. J Vasc Surg. 58:219–230. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Awad KS, West JD, de Jesus PV and MacLean
M: Novel signaling pathways in pulmonary arterial hypertension
(2015 Grover conference series). Pulm Circ. 6:285–294. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wilusz JE: A 360° view of circular RNAs:
From biogenesis to functions. WIREs RNA. e14782018. View Article : Google Scholar
|
